HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to two new employees as equity inducement awards outside of the Company’s 2017 Equity Incentive Plan, but … [Read more…]
Trial evaluates neuromodulation’s potential role in ulcerative colitis, the most common form of IBD MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–#clinicalresearch–Boomerang Medical, Inc., a women-led bioelectronic medicine company, today announced a $20 million Series B financing co-led by Arboretum Ventures and Hatteras Venture Partners. Proceeds will advance BOOM-IBD2, the first pivotal trial of implantable neuromodulation in inflammatory bowel … [Read more…]
Funding to support Phase 2b trial with MRM Health’s lead program MH002 in ulcerative colitis and advance two additional programs to IND approval Strategic partnership with Biocodex in biotherapeutics development and manufacturing adds significant non-dilutive funding in addition to the Series B financing Investment fuels expansion of proprietary CORAL® platform and pipeline GHENT, Belgium–(BUSINESS WIRE)–#Parkinson—MRM … [Read more…]
BEIJING–(BUSINESS WIRE)–#AntibodyDrugDiscovery—Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies and Merck, a leading science and technology company, have entered into an evaluation and option agreement to advance the development of antibody-conjugated lipid-based delivery solutions for nucleic acid payloads, … [Read more…]
MARLBOROUGH, Mass.–(BUSINESS WIRE)–$HOLX #holx–Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 23rd Annual Morgan Stanley Global Healthcare Conference in New York at 10:45 a.m. Eastern Time on Tuesday, September 9th. The fireside chat presentation will be webcast live and may be accessed through a link on the investors section of … [Read more…]
Helping students start the school year with a healthy smile NASHVILLE, Tenn.–(BUSINESS WIRE)–As students across Tennessee head back to school, Delta Dental of Tennessee (Delta Dental) is working to ensure that thousands of them are equipped with one of the simplest tools for good oral and overall health: a toothbrush. “Oral health is closely tied … [Read more…]
Research Could Eventually Lead to New Treatment Methods for Cancer or Diabetes ST. LOUIS–(BUSINESS WIRE)–Shriners Children’s researchers have developed a new way to use the body’s natural internal clock to optimize the delivery of medications and increase their effectiveness. Shriners Children’s St. Louis Director of Research Dr. Farshid Guilak recently published findings on a revolutionary … [Read more…]
Presentation details long-term safety and efficacy data on pegtibatinase as a potential treatment for classical HCU SAN DIEGO–(BUSINESS WIRE)–$TVTX #ICIEM2025–Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the Company shared two oral presentations in classical homocystinuria (HCU) at the International Congress of Inborn Errors of Metabolism, taking place September 2-6 in Kyoto, Japan. New long-term … [Read more…]
Agent Studio marks a turning point in clinical research, moving from human-heavy processes to scalable agents that streamline work and accelerate trials PALO ALTO, Calif.–(BUSINESS WIRE)–Medable, the leading technology provider for clinical development, today launched Agent Studio: the industry’s first agentic AI platform purpose-built for life sciences. Agent Studio is a no-code agent-builder that enables … [Read more…]
ST. LOUIS–(BUSINESS WIRE)–#Alzheimers—C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, is proud to announce that its early achievements while based in St. Louis are allowing it to triple the size of its operations in its hometown. C2N, a leader in advanced brain health diagnostics, will relocate its … [Read more…]
